Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2287]

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )

First in-human trials of rovalpituzumab for SCLC

Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA

First in-human trials of rovalpituzumab for SCLC ( Dr Charles Rudin - Memorial Sloan Kettering Cancer Center, New York, USA )

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO

ASCO 2016: Plenary Session Review ( Dr Julie Vose - President of ASCO )

Chemotherapy combination with capecitabine extends survival after pancreatic...

Prof John Neoptolemos - University of Liverpool, Liverpool, UK

Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery ( Prof John Neoptolemos - University of Liverpool, Liverpool, UK )

Latest in hepatocellular carcinoma treatments

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA

Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Randomised double blind phase III safety and efficacy trial of the proposed...

Dr Hope Rugo - University of California, San Francisco, USA

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Mechanistic studies of DNA repair

Tomas Lindahl - Nobel Prize for Chemistry 2015

Mechanistic studies of DNA repair ( Tomas Lindahl - Nobel Prize for Chemistry 2015 )

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA

Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

First outcome results from MINDACT breast cancer clinical trial ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

A presurgery combination therapy may improve outcomes for women with Her2...

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )

More from ecancer